Wockhardt Limited has informed the Exchange regarding a press release dated August 29, 2020, titled "Press Release".
Press Release Aug 29 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Wockhardt
- Press Release Aug 03 2020
- Wockhardt receives US FDA Qualified Infectious Disease Product designation for WCK 6777, a first ever once-a-day -lactam enhancer class antibiotic
- Wockhardt receives ANDA approval for pain medication Oxycodone liquid
- Wockhardt: Wockhardt launches generic version of anti-convulsant drug Lamictal XR
- Wockhardt: Wockhardt receives US FDA approval for generic version of Parkinsonism drug Requip XL®
Later from Wockhardt
- Press Release Aug 31 2020
- Press Release Nov 02 2020
- Press Release Dec 01 2020
- Press Release Jan 29 2021
- Press Release Feb 10 2021
Follow Wockhardt into a list and get an email when it puts out news.
Follow Wockhardt